Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nicholas C. Smith

Alto Neuroscience, Inc. reported in an 8-K filed August 27, 2026 that Nicholas C. Smith was appointed President and Chief Financial Officer, effective August 26, 2026.

“On August 26, 2026 (the "Effective Date"), the Board of Directors (the "Board") of Alto Neuroscience, Inc. (the "Company") promoted Nicholas C. Smith, the Company's Chief Financial Officer and Chief Business Officer, to the position of President and Chief Financial Officer, effective immediately.”
Alto Neuroscience, Inc. Form 8-K, filed August 27, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Alto Neuroscience, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.